News

Covid-19 Pandemic Spurs Adoption and Investment in Digital Health Technologies

Gareth King, Life Science Partner with Catapult Ventures looks at some of the most exciting areas and companies leading the transformation in digital health spurred by the Covid-19 pandemic.  See the full blog in Insider here

Cytox signs licence agreement with Cardiff University for polygenic risk score technology key to development of lead product genoSCORE(TM)

2nd September 2020: Oxford & Manchester, UK. Cytox Ltd, which provides non-invasive, risk assessment and patient stratification tools for Alzheimer's disease and dementia, has signed a license agreement with Cardiff University to access t...

Clin-e-Cal launches Crowdcube campaign

Clin-e-cal uses its patented Sound Response technology to develop apps to provide real-time feedback to inhaler users & facilitate remote disease management. With thousands of downloads, they're on a mission to help the world’s 500m asth...

Catapult Ventures announces investment in digital health start-up MyHelp

22nd July 2020 - Manchester, UK.  MyHelp, a Manchester based start-up building a digital solution for mental health service providers and patients has received investment from Catapult Ventures’ GM&C Life Sciences Fund. The company...

Catapult Ventures invests in agricultural synthetic biology start-up CroBio

15th July 2020, Alderley Park:  Catapult Ventures’ GM&C Life Sciences Fund is pleased to announce an investment in CroBio, an agricultural biotechnology start-up specialising in synthetic biology based at Alderle...

From our portfolio

Acea Health

Digital Healthcare Technology

viewview our portfolio

Our Team

Nick Wright

CEO

view complete team

Contact us

Alderley Park
Alderley Edge
Cheshire
SK10 4TG

Tel: 01625 344300

email